Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,126 | -38,776 | -23,999 | -13,231 | -115,455 |
| Depreciation Amortization | 212 | 159 | 105 | 52 | 205 |
| Other Working Capital | 5,538 | 150 | -535 | 3,238 | -1,712 |
| Other Operating Activity | 3,231 | 2,318 | 934 | 198 | 81,396 |
| Operating Cash Flow | $-49,145 | $-36,149 | $-23,494 | $-9,743 | $-35,567 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,000 | 10,000 | 0 | 0 | -75,000 |
| PPE Investments | -4 | N/A | N/A | N/A | -20 |
| Purchase Sale Intangibles | -136 | N/A | N/A | N/A | -1,000 |
| Other Investing Activity | 2,233 | 2,016 | 264 | 166 | -186 |
| Investing Cash Flow | $32,228 | $12,016 | $264 | $166 | $-75,206 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,955 | N/A | N/A | N/A | 137,897 |
| Other Financing Activity | -5,173 | 0 | 0 | 0 | -366 |
| Financing Cash Flow | $75,782 | $N/A | $N/A | $N/A | $137,531 |
| Exchange Rate Effect | -123 | -41 | -63 | -15 | 38 |
| Beginning Cash Position | 36,230 | 36,230 | 36,230 | 36,230 | 9,435 |
| End Cash Position | 94,973 | 12,057 | 12,937 | 26,639 | 36,230 |
| Net Cash Flow | $58,742 | $-24,173 | $-23,293 | $-9,592 | $26,796 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,145 | -36,149 | -23,494 | -9,743 | -35,567 |
| Capital Expenditure | -4 | N/A | N/A | N/A | -20 |
| Free Cash Flow | -49,149 | -36,149 | -23,494 | -9,743 | -35,587 |